Home » Knowledge Center » in vitro Evaluation of CAR-T Cell Cytotoxicity Using Flow Cytometry for Development of Potency Assays
in vitro Evaluation of CAR-T Cell Cytotoxicity Using Flow Cytometry for Development of Potency Assays
CD19 redirected chimeric antigen receptor (CAR) T cells have been successfully used in treating patients with B-cell leukaemia. In this study, we evaluated CD19 CAR-T cell cytotoxicity in vitro using flow cytometry for development of a potency assay The killing efficiency, the dose of the effectors, the time of co culture, the activation of CAR-T cells, and IFNy production have been examined
To learn more about how CD19 redirected chimeric antigen receptor (CAR) T cells can be used to treat patients with B-cell leukaemia, please complete the form below to download the poster: in vitro Evaluation of CAR-T Cell Cytotoxicity Using Flow Cytometry for Development of Potency Assays